Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics 2023. CA Cancer J Clin. 2023;73(1):17–48. https://doi.org/10.3322/caac.21763.
Yang Y, Xiong L, Li M, Jiang P, Wang J, Li C. Advances in radiotherapy and immunity in hepatocellular carcinoma. J Transl Med. 2023;21(1):526.
Article PubMed PubMed Central Google Scholar
Ronot M, Bouattour M, Wassermann J, Bruno O, Dreyer C, Larroque B, et al. Alternative Response Criteria (Choi, European association for the study of the liver, and modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 11 in patients with advanced hepatocellular carcinoma treated with sorafenib. Oncologist. 2014;19(4):394–402.
Article CAS PubMed PubMed Central Google Scholar
Jindal A, Thadi A, Shailubhai K. Hepatocellular carcinoma: etiology and current and future drugs. J Clin Exp Hepatol. 2019;9(2):221–32.
Article PubMed PubMed Central Google Scholar
Chen Z, Xie H, Hu M, Huang T, Hu Y, Sang N, et al. Recent progress in treatment of hepatocellular carcinoma. Am J Cancer Res. 2020;10(9):2993–3036.
CAS PubMed PubMed Central Google Scholar
Gravitz L. Liver cancer. Nature. 2014;516(7529):S1.
Article CAS PubMed Google Scholar
Orcutt ST, Anaya DA. Liver resection and surgical strategies for management of primary liver cancer. Cancer control: journal of the Moffitt Cancer Center. 2018;25(1):1073274817744621.
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.
Article CAS PubMed Google Scholar
Cai Y, Sun M, Xing J, Corke H. Antioxidant phenolic constituents in roots of Rheum officinale and Rubia cordifolia: structure-radical scavenging activity relationships. J Agric Food Chem. 2004;52(26):7884–90.
Article CAS PubMed Google Scholar
Bao MH, Wong CC. Hypoxia, metabolic reprogramming, and drug resistance in liver cancer. Cells. 2021;10(7):1715.
Article CAS PubMed PubMed Central Google Scholar
Bukowski K, Kciuk M, Kontek R. Mechanisms of multidrug resistance in cancer chemotherapy. Int J Mol Sci. 2020;21(9):3233.
Article CAS PubMed PubMed Central Google Scholar
Marin JJG, Macias RIR, Monte MJ, Romero MR, Asensio M, Sanchez-Martin A, et al. Molecular Bases of Drug Resistance in Hepatocellular Carcinoma. Cancers. 2020;12(6):1663.
Article CAS PubMed PubMed Central Google Scholar
Oshi M, Kim TH, Tokumaru Y, Yan L, Matsuyama R, Endo I, et al. Enhanced DNA Repair Pathway is Associated with Cell Proliferation and Worse Survival in Hepatocellular Carcinoma (HCC). Cancers. 2021;13(2):323.
Article CAS PubMed PubMed Central Google Scholar
Pavan ICB, de Oliveira AP, Dias PRF, Basei FL, Issayama LK, Ferezin CC, et al. On Broken Ne(c)ks and Broken DNA: The Role of Human NEKs in the DNA Damage Response. Cells. 2021;10(3):507.
Article CAS PubMed PubMed Central Google Scholar
Zhang S, Fu Y, Wang D, Wang J. Icotinib enhances lung cancer cell radiosensitivity in vitro and in vivo by inhibiting MAPK/ERK and AKT activation. Clin Exp Pharmacol Physiol. 2018;16:12966.
Che J, Lu YW, Sun KK, Feng C, Dong AJ, Jiao Y. Overexpression of TOB1 confers radioprotection to bronchial epithelial cells through the MAPK/ERK pathway. Oncol Rep. 2013;30(2):637–42.
Article CAS PubMed Google Scholar
Angulo JF, Moreau PL, Maunoury R, Laporte J, Hill AM, Bertolotti R, et al. KIN, a mammalian nuclear protein immunologically related to E. coli RecA protein. Mutat Res. 1989;217(2):123–34.
Article CAS PubMed Google Scholar
Seetharam A, Stuart GW. A study on the distribution of 37 well conserved families of C2H2 zinc finger genes in eukaryotes. BMC Genomics. 2013;14:420.
Article CAS PubMed PubMed Central Google Scholar
Mazin A, Milot E, Devoret R, Chartrand P. KIN17, a mouse nuclear protein, binds to bent DNA fragments that are found at illegitimate recombination junctions in mammalian cells. Mol Gen Genet MGG. 1994;244(4):435–8.
Article CAS PubMed Google Scholar
Mazin A, Timchenko T, Ménissier-de Murcia J, Schreiber V, Angulo JF, de Murcia G, et al. Kin17, a mouse nuclear zinc finger protein that binds preferentially to curved DNA. Nucleic Acids Res. 1994;22(20):4335–41.
Article CAS PubMed PubMed Central Google Scholar
Kannouche P, Pinon-Lataillade G, Tissier A, Chevalier-Lagente O, Sarasin A, Mezzina M, et al. The nuclear concentration of kin17, a mouse protein that binds to curved DNA, increases during cell proliferation and after UV irradiation. Carcinogenesis. 1998;19(5):781–9.
Article CAS PubMed Google Scholar
Masson C, Menaa F, Pinon-Lataillade G, Frobert Y, Chevillard S, Radicella JP, et al. Global genome repair is required to activate KIN17, a UVC-responsive gene involved in DNA replication. Proc Natl Acad Sci USA. 2003;100(2):616–21.
Article CAS PubMed PubMed Central Google Scholar
Biard DS, Saintigny Y, Maratrat M, Paris F, Martin M, Angulo JF. Enhanced expression of the Kin17 protein immediately after low doses of ionizing radiation. Radiat Res. 1997;147(4):442–50.
Article CAS PubMed Google Scholar
Masson C, Menaa F, Pinon-Lataillade G, Frobert Y, Radicella JP, Angulo JF. Identification of KIN (KIN17), a human gene encoding a nuclear DNA-binding protein, as a novel component of the TP53-independent response to ionizing radiation. Radiat Res. 2001;156(5 Pt 1):535–44.
Article CAS PubMed Google Scholar
Blattner C, Kannouche P, Litfin M, Bender K, Rahmsdorf HJ, Angulo JF, et al. UV-Induced stabilization of c-fos and other short-lived mRNAs. Mol Cell Biol. 2000;20(10):3616–25.
Article CAS PubMed PubMed Central Google Scholar
Chen J, Xia Y, Peng Y, Wu S, Liu W, Zhang H, et al. Analysis of the association between KIN17 expression and the clinical features/prognosis of epithelial ovarian cancer, and the effects of KIN17 in SKOV3 cells. Oncol Lett. 2021;21(6):475.
Article PubMed PubMed Central Google Scholar
Zeng T, Gao H, Yu P, He H, Ouyang X, Deng L, et al. Up-regulation of kin17 is essential for proliferation of breast cancer. PLoS ONE. 2011;6(9): e25343.
Article CAS PubMed PubMed Central Google Scholar
Jiang QG, Xiong CF, Lv YX. Correction to: Kin17 facilitates thyroid cancer cell proliferation, migration, and invasion by activating p38 MAPK signaling pathway. Mol Cell Biochem. 2021;476(2):741.
Article CAS PubMed Google Scholar
Wang Z, Jia R, Wang L, Yang Q, Hu X, Fu Q, et al. The Emerging Roles of Rad51 in Cancer and Its Potential as a Therapeutic Target. Front Oncol. 2022;12: 935593.
留言 (0)